Pfizer says its Covid-19 vaccine effective up to 6 months later

By: |
Updated: Apr 01, 2021 9:53 PM

Pfizer says its vaccine continues to be effective against COVID-19 up to six months later.

pfizer, pfizer vaccineRepresentative image

Pfizer says its vaccine continues to be effective against COVID-19 up to six months later. Pfizer and its German partner, BioNTech, announced updated results Thursday from their ongoing late-stage study of more than 44,000 volunteers.

The companies said the vaccine was 91 per cent effective against symptomatic disease and was even more protective in preventing severe disease. Of 927 confirmed COVID-19 cases detected through March 13, 77 were among people who received the vaccine and 850 were among people who got dummy shots.

There were no serious safety concerns and the vaccine also appeared to work against a variant first detected in South Africa, the companies said. The UK and US gave the emergency green light to roll out Pfizer’s vaccine late last year followed by many other countries. The vaccine is authorized for ages 16 and up.

This week, the companies said the vaccine is safe and strongly protective in kids as young as 12, based on a study of 2,260 US volunteers.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Lockdown should be last resort: PM Modi
2Govt aid will help vaccine production, says Poonawalla
3Vaccine ramp-up: Advance of Rs 4,500 crore to be paid to SII, Bharat Biotech